Guangdong Second Provincial General Hospital clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-20
What changed in the last 30 days
| First posted | New trial filing | Phase | Status |
|---|---|---|---|
| 2026-11-06 | NCT07920796 Thiotepa + TBI + Fludarabine + Etoposide for Allo-HSCT in Patients With R/R or High-risk… | Phase 2 | Enrolling by Invitation |
| 2026-10-27 | NCT07896655 Selective Intra-Arterial Hypothermia After Endovascular Treatment for Acute Basilar… | Not Yet Recruiting |
Active trials by phase
| Early Phase 1 | 1 | |
| Phase 1/2 | 1 | |
| Phase 2 | 3 | |
| Phase 2/3 | 1 |
Not charted: 3 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials
Leukemia (6) · Acute Myeloid Leukemia (AML) (4) · Multiple Myeloma (1) · Stroke (1)
Get alerts when Guangdong Second Provincial General Hospital's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.